Involvement of mitophagy in oncogenic K-Ras-induced transformation

References

• Attardi G, Schatz G. Biogenesis of mitochondria. Annu Rev Cell Biol 1988; 4:289 - 333; PMID: 2461720; http://dx.doi.org/10.1146/annurev.cb.04.110188.001445
   PubMedGoogle Scholar
• Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 2005; 37:822 - 834; PMID: 15694841; http://dx.doi.org/10.1016/j.biocel.2004.09.010
   PubMed Web of Science ®Google Scholar
• Brunk UT, Terman A, Cadenas E, Packer L. Understanding the process of aging 1999; New York Marcel Dekker 229 - 250
   Google Scholar
• Lemasters JJ. Selective mitochondrial autophagy or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction and aging. Rejuvenation Res 2005; 8:3 - 5; PMID: 15798367; http://dx.doi.org/10.1089/rej.2005.8.3
   PubMed Web of Science ®Google Scholar
• Kim I, Rodriguez-Enriquez, Lemasters JJ. Selective degradation of mitochondrial by mitophagy. Arch Biochem Biophys 2007; 462:245 - 253; PMID: 17475204; http://dx.doi.org/10.1016/j.abb.2007.03.034
   PubMed Web of Science ®Google Scholar
• Nowikovsky K, Reipert S, Devenish RJ, Schweyen RJ. Mdm38 protein depletion causes loss of mitochondrial K+/H+ exchange activity, osmotic swelling and mitophagy. Cell Death Differ 2007; 14:1647 - 1656; PMID: 17541427; http://dx.doi.org/10.1038/sj.cdd.4402167
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123:309 - 314; PMID: 13298683; http://dx.doi.org/10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Pedersen PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 1978; 22:190 - 274; PMID: 149996
   PubMedGoogle Scholar
• Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006; 25:4647 - 4662; PMID: 16892079; http://dx.doi.org/10.1038/sj.onc.1209607
   PubMed Web of Science ®Google Scholar
• Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24:68 - 72; PMID: 10098401; http://dx.doi.org/10.1016/S09680004(98)01344-9
   PubMed Web of Science ®Google Scholar
• Ziegler A, von Kienlin M, Decorps M, Remy C. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 2001; 61:5595 - 5600; PMID: 11454713
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gawlinski ET. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 2003; 63:3847 - 3854; PMID: 12873971
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004; 4:891 - 899; PMID: 15516961; http://dx.doi.org/10.1038/nrc1478
   PubMed Web of Science ®Google Scholar
• Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaría G, Kim H, et al. The bioenergetic signature of cancer: A marker of tumor progression. Cancer Res 2002; 62:6674 - 6681; PMID: 12438266
   PubMed Web of Science ®Google Scholar
• Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005; 26:2095 - 2104; PMID: 16033770; http://dx.doi.org/10.1093/carcin/bgi188
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 2007; 39:231 - 234; PMID: 17551816; http://dx.doi.org/10.1007/s10863-007-9081-2
   PubMed Web of Science ®Google Scholar
• Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006; 66:8927 - 8930; PMID: 16982728; http://dx.doi.org/10.1158/00085472.CAN-06-1501
   PubMed Web of Science ®Google Scholar
• Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005; 102:719 - 724; PMID: 15647368; http://dx.doi.org/10.1073/pnas.0408894102
   PubMed Web of Science ®Google Scholar
• Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G, et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 2005; 65:1655 - 1663; PMID: 15753359; http://dx.doi.org/10.1158/0008-5472.CAN-04-2012
   PubMed Web of Science ®Google Scholar
• Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990; 348:125 - 132; PMID: 2122258; http://dx.doi.org/10.1038/348125a0
   PubMed Web of Science ®Google Scholar
• Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62:851 - 891; PMID: 8352603; http://dx.doi.org/10.1146/annurev.bi.62.070193.004223
   PubMed Web of Science ®Google Scholar
• Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682 - 4689; PMID: 2547513
   PubMed Web of Science ®Google Scholar
• Friday BB, Adjei AA. K-ras as a target for cancer therapy. Biochim Biophy Acta 2005; 1756:127 - 144
   PubMed Web of Science ®Google Scholar
• Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 1996; 56:2224 - 2228; PMID: 8616876
   PubMed Web of Science ®Google Scholar
• Kitamura H, Kameda Y, Ito T, Hayashi H. Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol 1999; 111:610 - 622; PMID: 10230351
   PubMed Web of Science ®Google Scholar
• Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger-RNA are induced by ras or src oncogenes. Science 1987; 235:1492 - 1495; PMID: 3103217; http://dx.doi.org/10.1126/science.3103217
   PubMed Web of Science ®Google Scholar
• Ramanathan A, Wang C, Schreiber SL. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 2005; 102:5992 - 5997; PMID: 15840712; http://dx.doi.org/10.1073/pnas.0502267102
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee ES, You HJ, Lee JW, Park JW, Chun YS. Ras-dependent induction of HIF-1alpha785 via the the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 2004; 23:9427 - 9431; PMID: 15543236; http://dx.doi.org/10.1038/sj.onc.1208003
   PubMed Web of Science ®Google Scholar
• Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G, Kloog Y. Ras inhibition in glioblastoma downregulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res 2005; 65:999 - 1006; PMID: 15705901
   PubMed Web of Science ®Google Scholar
• Ohnami S, Matsumoto N, Nakano M, Aoki K, Nagasaki K, Sugimura T, et al. Identification of genes showing differential expression in antisense K; rastransduced pancreatic cancer cells with suppressed tumorigeniecity. Cancer Res 1999; 59:5565 - 5571; PMID: 10554036
   PubMed Web of Science ®Google Scholar
• Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, Der CJ. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phophatidylinositol-3-kinase signaling. Cancer Res 2007; 67:2098 - 2106; PMID: 17332339; http://dx.doi.org/10.1158/0008-5472.CAN-06-3752
   PubMed Web of Science ®Google Scholar
• Amann T, Hellerbrand C. GLUT1 as atherapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009; 13:1411 - 1427; PMID: 19874261; http://dx.doi.org/10.1517/14728220903307509
   PubMed Web of Science ®Google Scholar
• Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. J Biol Chem 2001; 276:9519 - 9525; PMID: 11120745; http://dx.doi.org/10.1074/jbc.M010144200
   PubMed Web of Science ®Google Scholar
• Lee JD, Yun M, Lee JM, Choi Y, Choi YH, Kim JS, et al. Analysis of gene expression profiles of hepatocellular carcinoma with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography. Eur J Nucl Med Mol Imaging 2004; 31:1621 - 1630; PMID: 15278306; http://dx.doi.org/10.1007/s00259004-1602-1
   PubMed Web of Science ®Google Scholar
• Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306:990 - 995; PMID: 15528435; http://dx.doi.org/10.1126/science.1099993
   PubMed Web of Science ®Google Scholar
• Adhami F, Liao G, Morozov YM, Schloener A, Schmithorst VJ, Lorenz JN, et al. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 2006; 169:566 - 583; PMID: 16877357; http://dx.doi.org/10.2353/ajpath.2006.051066
   PubMed Web of Science ®Google Scholar
• Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, et al. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007; 14:230 - 239; PMID: 16794605; http://dx.doi.org/10.1038/sj.cdd.4401984
   PubMed Web of Science ®Google Scholar
• Ogier-Denis E, Codogno P. Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta 2003; 1603:113 - 128; PMID: 12618311
   PubMed Web of Science ®Google Scholar
• Hippert MM, O'toole PS, Thorburn A. Autophagy in cancer: Good, bad or both?. Cancer Res 2006; 66:9349 - 9351; PMID: 17018585; http://dx.doi.org/10.1158/0008-5472.CAN-06-1597
   PubMed Web of Science ®Google Scholar
• Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672 - 676; PMID: 10604474; http://dx.doi.org/10.1038/45257
   PubMed Web of Science ®Google Scholar
• Liang XH, Yu J, Brown K, Levine B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res 2001; 61:3443 - 3449; PMID: 11309306
   PubMed Web of Science ®Google Scholar
• Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, et al. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol-3-kinase/protein kinase B pathway. J Biol Chem 2001; 276:35243 - 35246; PMID: 11477064; http://dx.doi.org/10.1074/jbc.C100319200
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102:8204 - 8209; PMID: 15928081; http://dx.doi.org/10.1073/pnas.0502857102
   PubMed Web of Science ®Google Scholar
• Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004; 23:2891 - 2906; PMID: 15077152; http://dx.doi.org/10.1038/sj.onc.1207521
   PubMed Web of Science ®Google Scholar
• Levine B, Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 2005; 115:2679 - 2688; PMID: 16200202; http://dx.doi.org/10.1172/JCI26390
   PubMed Web of Science ®Google Scholar
• Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptisis. Cell 2005; 120:237 - 248; PMID: 15680329; http://dx.doi.org/10.1016/j.cell.2004.11.046
   PubMed Web of Science ®Google Scholar
• Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation and tumorigenesis. Cancer Cell 2006; 10:51 - 64; PMID: 16843265; http://dx.doi.org/10.1016/j.ccr.2006.06.001
   PubMed Web of Science ®Google Scholar
• Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007; 14:500 - 510; PMID: 16990848; http://dx.doi.org/10.1038/sj.cdd.4402039
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Alveliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008; 4:151 - 175; PMID: 18188003
   PubMed Web of Science ®Google Scholar
• Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, et al. The signaling adaptor p62 is an important NKκB mediator in tumorigenesis. Cancer Cell 2008; 13:343 - 354; PMID: 18394557; http://dx.doi.org/10.1016/j.ccr.2008.02.001
   PubMed Web of Science ®Google Scholar
• Noguchi Y, Okamoto T, Marat D, Yoshikawa T, Saitoh A, Doi C, et al. Expression of facilitative glucose transpoter 1 mRNA in colon cancer was not regulated by k-ras. Cancer Lett 2000; 154:137 - 142; PMID: 10806301; http://dx.doi.org/10.1016/S03043835(00)00354-2
   PubMed Web of Science ®Google Scholar
• Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, et al. Autophagy facilitates glycolysis during Rasmediated oncogenic transformation. Mol Biol Cell 2011; 22:165 - 178; PMID: 21119005; http://dx.doi.org/10.1091/mbc.E10-06-0500
   PubMed Web of Science ®Google Scholar
• Yoon YS, Byun HO, Cho H, Kim BK, Yoon G. Complex II defect via downregulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest. J Biol Chem 2003; 278:51577 - 51586; PMID: 14512425; http://dx.doi.org/10.1074/jbc.M308489200
   PubMed Web of Science ®Google Scholar
• Yoon YS, Yoon DS, Lim IK, Yoon SH, Chung HY, Rojo M, et al. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J Cell Physiol 2006; 209:468 - 480; PMID: 16883569; http://dx.doi.org/10.1002/jcp.20753
   PubMed Web of Science ®Google Scholar